ASPIRA PATHLAB & DIAGNOSTICS | SONI MEDICARE | ASPIRA PATHLAB & DIAGNOSTICS / SONI MEDICARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.6 | -6.5 | - | View Chart |
P/BV | x | 2.6 | 3.4 | 76.8% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
ASPIRA PATHLAB & DIAGNOSTICS SONI MEDICARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
SONI MEDICARE Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / SONI MEDICARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 43 | 176.1% | |
Low | Rs | 26 | 20 | 131.5% | |
Sales per share (Unadj.) | Rs | 14.0 | 64.6 | 21.7% | |
Earnings per share (Unadj.) | Rs | -0.1 | -1.6 | 5.5% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 0 | -3,443.1% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 12.4 | 7.7 | 160.0% | |
Shares outstanding (eoy) | m | 10.29 | 4.26 | 241.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 0.5 | 744.9% | |
Avg P/E ratio | x | -583.7 | -19.7 | 2,967.3% | |
P/CF ratio (eoy) | x | 34.6 | -735.7 | -4.7% | |
Price / Book Value ratio | x | 4.1 | 4.0 | 101.2% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 518 | 132 | 391.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 56 | 99.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 275 | 52.5% | |
Other income | Rs m | 3 | 10 | 33.3% | |
Total revenues | Rs m | 148 | 285 | 51.9% | |
Gross profit | Rs m | 16 | -2 | -755.0% | |
Depreciation | Rs m | 16 | 7 | 242.1% | |
Interest | Rs m | 4 | 7 | 58.8% | |
Profit before tax | Rs m | -1 | -6 | 14.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 1 | 0.0% | |
Profit after tax | Rs m | -1 | -7 | 13.2% | |
Gross profit margin | % | 11.0 | -0.8 | -1,438.6% | |
Effective tax rate | % | 0 | -10.2 | 0.0% | |
Net profit margin | % | -0.6 | -2.4 | 25.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 116 | 50.3% | |
Current liabilities | Rs m | 16 | 108 | 14.7% | |
Net working cap to sales | % | 29.5 | 3.2 | 910.5% | |
Current ratio | x | 3.7 | 1.1 | 341.1% | |
Inventory Days | Days | 88 | 27 | 327.5% | |
Debtors Days | Days | 590 | 1,036,124 | 0.1% | |
Net fixed assets | Rs m | 115 | 84 | 136.1% | |
Share capital | Rs m | 103 | 43 | 241.3% | |
"Free" reserves | Rs m | 25 | -10 | -254.1% | |
Net worth | Rs m | 128 | 33 | 386.6% | |
Long term debt | Rs m | 10 | 50 | 19.4% | |
Total assets | Rs m | 173 | 201 | 86.3% | |
Interest coverage | x | 0.8 | 0.1 | 570.8% | |
Debt to equity ratio | x | 0.1 | 1.5 | 5.0% | |
Sales to assets ratio | x | 0.8 | 1.4 | 60.8% | |
Return on assets | % | 1.9 | 0.2 | 1,068.1% | |
Return on equity | % | -0.7 | -20.4 | 3.4% | |
Return on capital | % | 2.4 | 1.2 | 201.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 2 | -5.7% | |
From Investments | Rs m | 2 | -3 | -62.6% | |
From Financial Activity | Rs m | -9 | 3 | -296.8% | |
Net Cashflow | Rs m | -8 | 3 | -292.9% |
Indian Promoters | % | 18.7 | 69.8 | 26.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 30.2 | 269.0% | |
Shareholders | 1,512 | 1,086 | 139.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS NARAYANA HRUDAYALAYA METROPOLIS HEALTHCARE KIMS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | SONI MEDICARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.27% | 0.00% | 0.26% |
1-Month | -2.29% | 0.00% | 0.17% |
1-Year | -3.03% | 0.39% | 54.19% |
3-Year CAGR | 2.29% | -6.69% | 15.01% |
5-Year CAGR | -1.66% | -6.56% | 19.86% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the SONI MEDICARE share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of SONI MEDICARE the stake stands at 69.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of SONI MEDICARE.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
SONI MEDICARE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of SONI MEDICARE.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.